Adverse pregnancy outcomes among women in Norway with gestational diabetes using three diagnostic criteria.


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2023
Historique:
received: 11 02 2022
accepted: 08 01 2023
medline: 10 7 2023
pubmed: 6 7 2023
entrez: 6 7 2023
Statut: epublish

Résumé

The aim of this study was to examine the risk of adverse perinatal outcomes in women diagnosed with GDM by the World Health Organization (WHO) 1999 criteria, and in those retrospectively identified by the Norwegian-2017 and WHO-2013 criteria but not by WHO-1999 criteria. We also examine the effect of maternal overweight/obesity and ethnicity. We used pooled data from four Norwegian cohorts (2002-2013), encompassing 2970 mother-child pairs. Results from universally offered 75-g oral glucose tolerance tests measuring fasting plasma glucose (FPG) and 2-hour glucose (2HG) were used to assign women into three diagnostic groups: Diagnosed and treated by WHO-1999 (FPG≥7.0 or (2HG ≥7.8 mmol/L), identified by WHO-2013 (FPG ≥5.1 or 2HG ≥8.5 mmol/L), and identified by Norwegian-2017 criteria (FPG ≥5.3 or 2HG ≥9.0 mmol/L). Perinatal outcomes included large-for-gestational-age (LGA) infants, cesarean section, operative vaginal delivery, preterm birth and preeclampsia. Compared to the non-GDM group, women diagnosed with GDM by either of the three criteria had an increased risk of large-for-gestational-age infants (adjusted odds ratios (OR) 1.7-2.2). Those identified by the WHO-2013 and Norwegian-2017 criteria but not diagnosed and treated by WHO-1999 criteria had an additional increased risk of cesarean section (OR 1.36, 95% CI 1.02,1.83 and 1.44, 95% CI 1.03,2.02, respectively) and operative vaginal delivery (OR 1.35, 95% CI 1.1,1.7 and 1.5, 95% CI 1.1,2.0, respectively). The proportions of LGA neonates and cesarean section were higher for women with GDM in both normal-weight and overweight/obese women. Asians had a lower risk of delivering large-for-gestational-age infants than Europeans applying national birthweight references, but maternal glucose values were similarly positively associated with birthweight in all ethnic groups. Women who met the WHO-2013 and Norwegian-2017 criteria, but were not diagnosed by the WHO-1999 criteria and therefore not treated, had an increased risk of LGA, cesarean section and operative vaginal delivery compared to women without GDM.

Identifiants

pubmed: 37410781
doi: 10.1371/journal.pone.0280750
pii: PONE-D-22-04306
pmc: PMC10325062
doi:

Substances chimiques

Glucose IY9XDZ35W2

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0280750

Informations de copyright

Copyright: © 2023 Rai et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

World Health Organ Tech Rep Ser. 1980;646:1-80
pubmed: 6771926
N Engl J Med. 2008 May 8;358(19):1991-2002
pubmed: 18463375
BMC Public Health. 2013 Feb 13;13:132
pubmed: 23406306
PLoS One. 2017 Mar 2;12(3):e0172946
pubmed: 28253366
J Matern Fetal Neonatal Med. 2010 Jan;23(1):74-81
pubmed: 19626569
Diabetes Care. 2003 Jan;26(1):193-8
pubmed: 12502680
Front Endocrinol (Lausanne). 2018 Nov 15;9:682
pubmed: 30524375
Nat Rev Dis Primers. 2019 Jul 11;5(1):47
pubmed: 31296866
Sci Rep. 2018 Sep 6;8(1):13392
pubmed: 30190548
J Perinat Med. 2017 Apr 1;45(3):359-366
pubmed: 27508951
Diabetologia. 2015 Sep;58(9):2003-12
pubmed: 26071759
Can J Diabetes. 2017 Dec;41(6):596-602
pubmed: 28454899
Diabetes Care. 2010 Mar;33(3):676-82
pubmed: 20190296
Acta Obstet Gynecol Scand. 2000 Jun;79(6):440-9
pubmed: 10857867
Obstet Gynecol. 2015 Jul;126(1):67-73
pubmed: 26241258
Diabetes Care. 2012 Apr;35(4):780-6
pubmed: 22357187
J Epidemiol Community Health. 2013 Jul;67(7):544-51
pubmed: 23592862
BJOG. 2020 Jan;127(1):116-122
pubmed: 31553136
Reprod Toxicol. 2011 Sep;32(2):205-12
pubmed: 21620955
Diabetologia. 2014 Dec;57(12):2492-500
pubmed: 25273345
Diabetologia. 2005 Sep;48(9):1736-42
pubmed: 16052327
Obstet Gynecol. 2012 Jan;119(1):29-36
pubmed: 22183208
BMC Pregnancy Childbirth. 2021 Sep 8;21(1):615
pubmed: 34496778
Int J Endocrinol. 2013;2013:248121
pubmed: 23365571
BJOG. 2010 Apr;117(5):575-84
pubmed: 20089115
Diabetes Care. 2016 Dec;39(12):2204-2210
pubmed: 27634392
Scand J Public Health. 2010 Nov;38(5 Suppl):60-70
pubmed: 21062840

Auteurs

Anam Shakil Rai (AS)

Department of Research, Sorlandet Hospital, Kristiansand, Norway.

Line Sletner (L)

Department of Pediatric and Adolescents Medicine, Akershus University Hospital, Nordbyhagen, Akershus, Norway.
Institute of Clinical Medicine, University of Oslo, Oslo, Norway.

Anne Karen Jenum (AK)

Department of General Medicine, General Practice Research Unit (AFE), Institute of Health and Society, University of Oslo, Oslo, Norway.

Nina Cecilie Øverby (NC)

Department of Nutrition and Public Health, Faculty of Health and Sport Sciences, University of Agder, Kristiansand, Norway.

Signe Nilssen Stafne (SN)

Department of Public Health and Nursing, Norwegian University of Science and Technology (NTNU), Trondheim, Norway.
Department of Clinical Services, St.Olavs Hospital Trondheim University Hospital, Trondheim, Norway.

Elisabeth Qvigstad (E)

Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
Department of Endocrinology, Morbid Obesity and Preventive Medicine, Oslo University Hospital, Oslo, Norway.

Are Hugo Pripp (AH)

Oslo Centre of Biostatistics and Epidemiology, Research Support Services, Oslo University Hospital, Oslo, Norway.

Linda Reme Sagedal (LR)

Department of Research, Sorlandet Hospital, Kristiansand, Norway.
Department of Obstetrics and Gynaecology, Sorlandet Hospital, Kristiansand, Norway.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH